Introduction
Since the indirect m e h r e m e n t o f hlood pressure based o n the principle of arterial occlusion using a forearm cuff was introduced by Scipione Kiva-Rocci in 1896 111 and subsequently nlodifiecl t o incorporate auscultation by Nicolai Korotkolf in 1905 (21, this technique h:a been the universal method used in the assessment of blood pressure in medial practice. Most of the evidence showing that the antihypertensive drugs in everyday use lower blood pressure derives from studies of clinic blood pressure measured by this technique 13-51. However, it is well known that casual blood pressure measured in the clinic may be influenced by a number of factors and as long ago as 1904, Theodore Janeway, writing before Korotkoff had reported the now accepted auscultatory method of measuring blood pressure, showed that stress could raise blood pressure 161.
Factors influencing bl'bod pressure measurement
Apart from potential error and inconstancies in technique 171, random variation of blood pressure readings is large; in one study a series of 40 readings from individuals o n 2 0 d 8 e r e n t occasions showed a within-subject range of 25-39mmHg [8] . Moreover, there is the circadian variation of blood pressure whereby blood pressure reaches its highest level at mid-morning, to fall thereafter throughout the day to its nadir in sleep with a rise again before waking (91.
Another confounding factor is the alarm o r alerting reaction whereby the mere presence of the physician performing the measurement can induce substantial increases in blood pressure [lo] . This phenomenon is also present, albeit t o a lesser degree, when blood pressure is measured by a technician [ I 11 o r a nurse 1121. Recently, Pickering ancl his ~o l l e a g u d~o r t e d that 21% of 292 patients with borderl-rtension diagnosed by clinic measurement h a d y rmal daytime ambulatory pressure [ 11 ] . These patients with 'white coat' hypertension did not show any generalized incrrdse in blood pressure lability o r exaggerated pressor response while at work. In a study of 638 patients with hypertension we found that using the World Health Oorganization level of hypertension (blood pressure 2 160/95 m m~g ) 89% of these patients would have been diagnosed hypertensive by the fvnily practitioner, 65% by the hospital clinic and 46% by ambulatory blood pressure [13] .
When attempting to ascertain the effect of drugs o n blood pressure, good trial design can reduce the i d uence of factors affecting the measurement technique and blood pressure behaviour. Multiple recordings of blood pressure may reduce error from random variation, and taking blood pressure at the same time of day throughout a study should minimize errors associated with circadian variation. A cross-over design in which recordings are performed by the same doctor o r nurse in the same room under standardized conditions reduces, but does not necessarily remove, error from the alarm reaction.
Assessing blood pressure lowering effect
One of the most surprising aspects of research into the efficacy of antihypertensive drugs, is the readiness with which a blood pressure lowering effect observed at o n e moment in the 24-h cycle, often without reference to the time of drug administration, is taken to indicate therapeu-tic efficacy through the day. It is, of course, difficult, if not impossible, to demonstrate tlie duration of drug effect with clinic measurement as repeated readings are tedious to perform Imth for tlie patient and investigator. In any event, the methodology of conventional blood pres: sure measurement in many of these studies leaves much to be desired [14] . However, with the increasing use of new formulations of drugs that permit once and twice daily dosage in an effort to improve compliance [ 1 5 ] , it is now more important than ever to be able to assess acchrately the duration of drug effect. Furthermore, studies using ambulatory techniques have demonstrated the naivety of assessing die response to antihypertensive treatment by conventional clinical measurement alone [ 1 6 ] . 1'0 overcome the lin~itations of infrequent clinic measurements in assessing the efficacy and duration of action of antihypertensive drugs, self-rrieasurement and ambulatory measurement have been used.
Self-measurement of blood pressure
Since Brown's observation in 1930 that blood pressure measured in tlie home was lower than that recorded by a doctor [ 1 7 ] , the discrepancy between pressures recorded in the home and the clinic has often been confirmed . Assessed against clinic measurements, blood pressure recorded in the home is accurate whether measured by patients [20] o r their relatives o r friends 121 1, and the technique can 'detect small average changes in blood pressure 1221. The usefulness of self-measurement of blood pressure in the assessment of the effects of therapy has been shown in several studies [19, 23, 24] . However, the technique has the disadvantage of being deperident o n the ability of the subject to measure his o r her blood pressure. Also, the patient's over-reaction to the normal fluctuations in blood pressure associated with daily living may cause psychological distress and affect the results in an unpredictable fashion [ 2 5 ] . The technique is further limited in that it is dependent o n the subject's participation and cannot, therefore, give multiple readings during the day o r any assessment of nocturnal blood pressure.
on-invasive ambulatory treatment
Tlie first step towards achieving a profile of blood pressure during. normal activity was the development of a portable apparatus,for direct recording of blood pressure in 1969 [ 2 6 ] , which allowed assessment of the antihypertensive effect of blood pressure lowering drugs over a period [27, 28] . However, being invasive, ethical considerations limit the application of this approach. Therefore, much effort has been directed to the development of non-invasive measuring devices which can b e used repeatedly in the same patient. The early devices required participation by the subject who had to inflate tlie cuff at prescribed intervals and were therefore limited to daytime recording [ 2 9 ] , but now fully automated recorders are available with automatic cuff inflation allowing the recording of blood pressure over 24-h [30, 31] .
There are certain disadvantages, however, with non-invasive ambulatory measurement. The cost of the equipment is high, maintenance costs are often sudtantial, and the finance for a technician may have to be taken into consideration [ 3 2 ] . There is then the problem of accuracy. Devices should not be purchased (ideally they should not be marketed) unless the manufacturers provide independent validation of accuracy, preferably published in a reputable journal 1331 and this is rarely done. Because of the variation in the methodology and statistical analysis of validation studies of ambulatory devices, it is not easy to make dogmatic assertions about the accuracy of the many devices now available. However, the American Association for the Advancement of Medical Instrumentation has recently published a standard for electronic and automated sphygmomanometers [34] which is now being used for assessing new devices [35] and the British Hypertension Society is preparing a standardized protocol for validation which will permit comparison between studies, and hopefully allow prospective purchasers to make reasoned decisions o n the basis of independent assessment.
The placebo effect of measurement
The existence of the placebo effect in the treatment of a variety of diseases is a well-substantiated phenomenon 1361. Because clinic blood pressure falls in response to placebo in most hypertensive patients [37, 38] , placebo control has routinely been incorporated into the design of antihypertensive drug studies. An important observation with ambulatory blood pressure measurement is that blood pressure monitored intra-arterially is not subject to the placebo effect [ 3 9 ] .
While non-invasive ambulatoty measurement has been found to be free of placebo effect in most studies [40] [41] [42] [43] , this has not been the experience in all cases [ 4 4 ] . Tlie absence of a placebo effect with indirect ambulatory monitoring, if confirmed, would greatly simplify the design and conduct of efficacy studies of antihypertensive dnigs. For example, many studies employ a randomized placebocontrolled cross-over design, o n the basis that a comparison between treatments in the same subject is more precise and requires fewer subjects than a comparison between subjects. In such studies, a wash-out period before patients, cross-over treatments is recommended to reduce the possibility of a treatmenwriod interaction [45] . However, if there was n o placebo effect with ambulatory blood pressure monitoring, then measurement performed before and repeated at the end of the treatment period would suffice, making the cross-over design with its risks of carryover effects.unnecessary. In fact, this approach has been adopted by Raftery and his colleagues for the last 7 years using direct intra-arterial ambulatory blood pressure measurement [ 4 6 5 0 ] .
Ambulatory measurement and antihypertensive drug efficacy
For the past decade it has been our policy to incorporate ambulatory measurement into the study protocols of blood pressure lowering drugs [51-561. Initially, w e used daytime ambulatory measurement in double-blind, crossover studies of drug efficacy. From the results of these and other similar studies a number of patterns emerge.
Firstly, ambulatory blood pressure may b e in agreement with clinic blood pressure measurements [56] [57] [58] [59] [60] [61] . In such studies, where a clinic fall in blood pressure is confirmed by an~bdatory blood pressure measurement, the latter also demonstrates what conventional measurement can never show, namely the pattern of an antihypertensive effect over the dosing interval.
Secondly, conventional clinic measurement may fail to detect the blood pressure lowering effect, demonstrated by ambulatory measurement [51, 55, 62, 63] . The studies showing this phenomenon used smaller numbers (six patients [51]; 11 patients [551; 12 patients 1621; seven patients [63] ), and for this reason their power to detect differences between treatments with clinic measurement was low. However, the greater number of observations available with ambulatory measurement, by reducing withinsubject variability, greatly increases their power. For example, applying the power calculations for cross-over studies described by Hills and Armitage [45] to the data from o n e of these studies [55] , it can be shown that eight patients would be required if ambulatoly measurement was used to assess blood pressure lowering effect (to achieve a power of 85%), whereas 30 patients would b e needed with clinic measurement. Ambulatory blood pressure measurement may also afford a means of determining patients likely to respond to drug treatment. In a recent study diltiazem decreased average whole-day blood pressure by 18/13 mmHg in patients whose clinically cliagnosed hypertension was confirmed by pre-treatment 24-h blood pressure, but by only 0/1 mmHg in those whose 24-h pressures were normal [&] . This suggests that there are differing antihypertensive responses among patients diagnosed as hypertensive in the clinic, and those in whom hypertension is confirmed by 24-h ambulatory measurement. Given the increasing demands for and the high costs of studies of blood pressure lowering agents, the potential of ambulatory blood pressure to demonstrate clinically significant reductions using smaller samples than those required using clinic measurement [41] o r by determining responder status, has important implications.
Finally, reductions in clinic blood pressure may b e significant, but ambulatory blood pressure measurement may b e either non-confirmatory [44, 52, 53, 6547] , o r show that the clinic reduction coincides only with a brief period of ambulatory reduction [54] . Thus, in a study of the antihypertensive efficacy of verapamil in the elderly evaluated by ambulatory blood pressure measurement where clinic blood pressure assessments were carried out within 4 h of dosing, a marked effect o n clinic measurement was observed; ambulatory measurement revealed that control was poor for the remainder of the expected duration of the d n~g ' s action [54] . However, in other sh~dies using ambulatory measurement [44, 52, 53 ,6>71] this loss of blood pressure control was not observed, raising another possibility, namely that the physiological basis of blood pressure elevation in the clinic mav b e different from that outside the clinic and that the dose of an antihypertensive agent effective in lowering clinic blood pressure may not be effective in reducing ambulatory blood pressure. This hypothesis is supported by the observation that nitrendipine reduces blood pressure effectively in the clinic, but this effect is blunted o n ambulatory measurement during work periods [66] , possibly due to increased adrenergic activity associate with work. Similarly comparison of the P-blocker timolol with methyldopa showed similar significant reductions in clinic measurement, but ambulatory blood pressure was significantly reduced with timolol only [65] . Likewise, both the P-blocker, betaxolol, and verapamil reduced clinic blood pressure, but only betaxolol significantly reduced ambulatory blood pressure [67] . These studies suggest that 0-blocking drugs have a sustained effect on ambulatory blood pressure not shared by drugs with other modes of action. Of considerable practical importance is the fact that many preparations would have been declared as quite efficacious blood pressure lowering agents by conventional measurement, whereas ambulatory measurement showed a pattern of activity that was far less impressive.
Future prospects for ambulatory measurement
Ambulatory blood pressure measurement in the words of Norman Kaplan, is 'an idea whose time has come' [68] . It is also moving into a new phase of development. In most of the studies cited, ambulatory measurement was carried out over a 12-16 h period simply because the devices used were not fully automated thus making night-time measurements impractical. With the new generation of ambulatory recorders, it is possible to obtain 24-h ambulatory measurement which provides not only further evidence of the duration of drug effect but also demonstrates the circadian rhythm of blood pressure. This latter facility, quite apart from being of value in the assessment of antihypertensive drugs, may also have important prognostic implications. There is some evidence that hypertensive patients who d o not have a nocturnal fall in blood pressure (non-dippers) are at greater risk than the majority who show a significant reduction in nocturnal blood pressure (dippers) [691.
The possibility a l s m -that antihypertensive drugs with a prolonged duration of effect, ~r Zdministered frequently, may cause a profound reduction in nocturnal blood pressure in 'dippers', and that such hypotension might lead to myocardial ischaemia and infarction [70] . While the prognostic and therapeutic implications of these findings require further evaluation, they provide cogent evidence in favour of assessing the effects of antihypertensive therapy o n sleeping blood pressure, an area where w e feel further research is urgently required.
Conclusions
The benefits of ambulatoty blood pressure monitoring in the assessment ofzhe efficacy of drug treatment are now well established. Conventional clinic measurement is influenced by many factors which make the technique unsuitable for research into drug efficacy, but more importantly, clinic measurement cannot provide assessment of duration of effect, nor of the effect of antihypertensive drugs o n sleeping pressure. Lf it can be confirmed that non-invasive ambulatory blood pressure measurement is free of any placebo effect, then it is possible that the design of antihypertensive drug studies could be greatly simplified. The greatest potential for ambulatoty blood pressure measurement in assessing drug efficacy may be its ability to reduce significantly the numbers of patients needed in such studies. The time has surely come where studies of antihypertensive drug efficacy which d o not assess blood pressure over 24 h should no longer be acceptable. Nifedipine tablets for systemic hypertension: A study using continuous ambulatory intra-arterial recording. 
Introduction
It is well established that blood pressure in Western society rises with age [1, 2] . It is also well known that arteries stiffen with age, usually as a result of medial calcification due to Monckeberg's arteriosclerosis [3] . The determination of blood pressure by indirect methods depends on collapse of the brachial artery when pressure within the cuff exceeds that within the vessel. It has therefore been argued that age-related increases in arterial stiffness could lead to spuriously high indirect blood pressure measurements [ 4 ] . Furthermore, it has been suggested that this condition, referred to as pseudohypertension, may be associated with an overdiagnosis of hypertension in older patients [5] . However, it remains to be shown whether blood pressure in patients with 'stiff arteries' is higher than in agematched controls. To address this important question, an easily performed test of arterial stiffness is required. A suitable test is the procedure first proposed by Sir William Osler in 1892, who stated that if, when the radial artery was compressed, the artery could be felt beyond the point of compression, then its walls were sclerosed [61. This test has been modified slightly and has become known as Osler's manoewre [7] . A patient is described as being Osler's manoeuvre positive if, when a blood pressure cu8 is inflated above systolic pressure, either the brachial or radial arteries are clearly palpable.
The aims of this study were to assess the prevalence of arterial stiffness in an elderly population, using Osler's manoeuvre, and to ascertain whether blood pressure dif fers between those with and without arterial stiffness.
Patients and methods
We assessed a total of 250 hospital inpatients (ranging in age from 16-98 years) from the general medical and geri. atric wards at St James's Hospital. The patients were cho sen randomly. At the time of analysis, 36 patients wert hypertensive, 22 were taking drug treatment and 14 hac' taken drug treatment previously. Because of the high de gree of interobserver variation associated with this clini cal sign [8] , patients were classified as being Osler's man oeuvre positive or negative by two doctors, each not know ing the other's findings. Only data from those patients fo whom both doctors agreed on the Osler's manoewre sta tus were used in the analysis. Recordings of blood pressurc were made using a standard mercury sphygrnomanome ter, with the patient in the sitting position, Korotkoff phasc V being taken for the diastolic pressure [9] . Assessment. were made using the right arm unless the clinical situatiot dictated otherwise. Age, sex, blood pressure and antihypet tensive drugs were recorded.
Results
The two doctors agreedon the Osler's manoewre staht in 198,patients (79%), of whom just over half were malc A positive Osler's manoewre was uncommon under th age of 50 years (four of 46 patients; 8.7%) but becam more common thereafter, rising to 58% of patients age over 75 years. Blood pressure levels were similar in eac age group irrespective of Osler's manoeuvre status (Tab1 1). Of the 22 patients taking antihypertensive medicatiot The sensitivity of a sign is defined as the conditional probability that if that sign is present, then the disease is also present [12] . That there was no dierence in blood pressure between the positive and negtive groups of patients casts some doubt on the sensitivity of the sign as a predictor of spuriously elevated cuff pressures in a population of elderly patients. This contrasts with the findings of Messerli et aL 171, who reported cuff systolic and diastolic blood pressures that averaged l6mrnHg higher than direct intra-arterial measurements in 13 elderly Osler's manoeuvre positive hypertensive patients. However, Messerli et al recruited the patients from a specialized blood pressure clinic and did not select consecutive cases.
Osler's manoeuvre has been suggested as a screening test in the assessment of elderly hypertensive patients, to identify those in whom intra-arterial pressure needs to be measured [5] . However, in view of the findings from this study, we recommend further research into the sensitivity of this sign before it can be advocated for routine use in the assessment of older hypertensive patients.
